Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

124.63 +1.77 (+1.44%)
Official Closing Price Updated: 4:10 PM EST, Feb 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,766,417
Open 122.70
Bid (Size) 124.09 (1,100)
Ask (Size) 124.35 (100)
Prev. Close 122.86
Today's Range 122.10 - 125.45
52wk Range 66.66 - 132.09
Shares Outstanding 541,500
Dividend Yield 1.31%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
IBRX Stock Jumps 6% Pre-Market On BCG Update In Saudi Arabia – Retail Says Share Price Is ‘Attractive’ ↗
The Saudi Food and Drug Authority encouraged the company to submit a regulatory filing for its recombinant Bacillus Calmette-Guérin, which the company expects to submit within weeks. 
Via Stocktwits
News headline image
IBRX Stokes Retail Chatter — Investors See Anktiva Beat Merck’s Keytruda With Approval In EU ↗
Retail investors are now looking forward to a full approval of Anktiva in the EU for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ. 
Via Stocktwits

Performance

YTD
+2.6%
+2.6%
1 Month
-0.5%
-0.5%
3 Month
+8.5%
+8.5%
6 Month
+38.2%
+38.2%
1 Year
+36.5%
+36.5%

More News

Read More
News headline image
RARE Stock Slumps On Multiple Wall Street Price Target Slashes, Clinical Pipeline Uncertainty ↗
Via Stocktwits
News headline image
VKTX Stock Rallies After Hours On Optimism Around Company’s Obesity Pipeline ↗
Via Stocktwits
Why IBRX Stock Is One Of The Biggest Pre-Market Movers Today ↗
Via Stocktwits
IBRX Stock Finds Retail Cheer After Company’s Immunotherapy For Bladder Cancer Gets Saudi FDA Approval ↗
Via Stocktwits
Why Did NRXP Stock Surge 21% Pre-Market Today? ↗
Via Stocktwits
IBRX Garners Retail Attention On Positive Update In Immunotherapy For Lung Cancer Patients ↗
Via Stocktwits
News headline image
Biotech Beat Nvidia in 2025. Can It Do It Again? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Sector Alert: 4 Healthcare ETFs Poised for Explosive Growth Now ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
Why Did UPB Stock Pop 20% In Pre-Market Today? ↗
Via Stocktwits
News headline image
Why Did RGNX Shares Plummet 19% After-Hours Today? ↗
Via Stocktwits
Why Did TVTX Stock Crash 30% In Pre-Market Today? ↗
Via Stocktwits
IMRX Stock Closed Over 20% Higher Today: Here’s Why ↗
Via Stocktwits
News headline image
MDXG Stock Rises As MiMedx Enters Into Exclusive Distribution Agreement For Three Products ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
RGNX Stock Is Falling Today — What Is The FDA Update On REGENXBIO's Gene Therapy? ↗
Via Stocktwits
News headline image
Why Did MNKD Stock Jump Over 7% In Pre-Market Today? ↗
Via Stocktwits
News headline image
The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market
Via MarketMinute
Topics Artificial Intelligence ETFs Initial Public Offering
News headline image
Why NVAX Stock Is Popping Pre-Market – And What Does Pfizer Have To Do With It? ↗
Via Stocktwits
News headline image
Why Did GLUE Stock Surge Over 50% In Premarket Today? ↗
Via Stocktwits
News headline image
Healthcare Sector Falters: S&P 500's Biggest Loser Amid Broader Market Caution
Via MarketMinute
Topics ETFs Economy Intellectual Property
News headline image
Eaton, FTAI Aviation And More On CNBC's 'Final Trades' ↗
Via Benzinga
Topics ETFs Stocks
News headline image
Biotech Insiders Are Spending Billions. Trump Favors Less Oversight. One Biotech ETF Could Ride the Surge. ↗
Via The Motley Fool
Topics ETFs Economy Government
News headline image
Money Moving Into Healthcare Not AI; Four Fed Presidents Do Not Want a Rate Cut; Euphoria Wearing Off ↗
Via Benzinga
Topics Economy
News headline image
Taiwan Semiconductor, HealthEquity, Cboe Global Markets And More: CNBC's 'Final Trades' ↗
Via Benzinga

Frequently Asked Questions

Is State Street SPDR S&P Biotech ETF publicly traded?
Yes, State Street SPDR S&P Biotech ETF is publicly traded.
What exchange does State Street SPDR S&P Biotech ETF trade on?
State Street SPDR S&P Biotech ETF trades on the New York Stock Exchange
What is the ticker symbol for State Street SPDR S&P Biotech ETF?
The ticker symbol for State Street SPDR S&P Biotech ETF is XBI on the New York Stock Exchange
What is the current price of State Street SPDR S&P Biotech ETF?
The current price of State Street SPDR S&P Biotech ETF is 124.63
When was State Street SPDR S&P Biotech ETF last traded?
The last trade of State Street SPDR S&P Biotech ETF was at 02/17/26 04:10 PM ET
What is the market capitalization of State Street SPDR S&P Biotech ETF?
The market capitalization of State Street SPDR S&P Biotech ETF is 67.49M
How many shares of State Street SPDR S&P Biotech ETF are outstanding?
State Street SPDR S&P Biotech ETF has 67M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.